|
Princeton, NJ,
September 17, 2007 - Covance Inc. (NYSE:
CVD ) today announced
the addition of a state-of-the-art Interactive Web
Response service for randomization and drug supply
management, powered by Clarix IVRS R4. This new
service offers customers leading-edge IVR/IWR technology
solutions and access to the clinical resources and
expertise of one of the world's largest drug development
services companies.
"Nowhere
else in the market today can IVR/IWR customers get
access to project managers with such a wealth of
resources on hand, whether that be in-house PhD
statisticians and physicians, or state-of-art technology
solutions, such as this," said Brian O'Callaghan,
General Manager & Vice President, Covance IVRS &
Cardiac Safety Services. "We provide customers the
unique combination of world-class technology, in-depth
clinical trial expertise and extensive multinational
clinical resources. A service offering with
leading-edge technology and access to this degree of
clinical trial know-how is not available anywhere else
in the industry."
As
one of the only full-service drug development services
company with a dedicated, in-house IVR system, Covance
designs and develops IVR technology solutions to help
customers manage patient screening and enrollment,
randomization, and drug supply management from a
clinical perspective.
The
Clarix IVR/IWR technology platform sets the standard for
clinical technology solutions in the industry and
enables Covance to expand its delivery of technological
and clinical expertise to the web.
"The
Clarix IVRS R4 is the most advanced fully web-integrated
IVRS in the industry today. It offers unparalleled
deployment speed, leading-edge functionality, and
powerful reporting capability," said Jagath Wanninayake,
Chief Executive Officer and Founder of Clarix. "Our
advanced IVR/IWR product, coupled with the depth of
Covance IVRS project management expertise, is a very
compelling value proposition for Covance
customers."
Covance
has provided IVRS to the pharmaceutical, biotechnology
and medical device industries since 1989 and was the
first to apply the technology to the clinical trial
process. Covance IVRS uses industry-proven
evolving technologies and superior consultative service
to develop innovative methods for supporting clinical
trials. Covance provides comprehensive IVRS and
related support services tailored to meet the needs of
each clinical protocol and add value to every program
using
IVRS.
| 
